Cargando…
Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
In the previous paper of ours we compared, prior to start any treatment, a number of immunological parameters in 24 chronic myeloid leukemia patients with the same number of healthy subjects matched by age and sex. We found significant differences in the levels of immunoglobulins, the C4 component o...
Autores principales: | Humlová, Zuzana, Klamová, Hana, Janatková, Ivana, Malíčková, Karin, Králíková, Petra, Šterzl, Ivan, Roth, Zdeněk, Hamšíková, Eva, Vonka, Vladimír |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004381/ https://www.ncbi.nlm.nih.gov/pubmed/21197073 http://dx.doi.org/10.1155/2010/137320 |
Ejemplares similares
-
Rice proteins recognized by immunoglobulin E antibodies of patients with food allergies
por: Tuckova, Ludmila, et al.
Publicado: (2014) -
Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases
por: Malíčková, Karin, et al.
Publicado: (2012) -
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
por: Malíčková, Karin, et al.
Publicado: (2011) -
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017) -
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy
por: Pavlík, Tomáš, et al.
Publicado: (2011)